Elite Pharmaceuticals, a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, has entered into a new development and license agreement with SunGen Pharma to collaborate, develop and commercialize generic pharmaceutical products based upon a unique drug delivery platform used for extended release products. The parties intend to begin with the development of five generic extended release products and to develop additional such products after that. More th...